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The diploid, polymorphic yeast Candida albicans is one of the most important human
pathogenic fungi. C. albicans can grow, proliferate and coexist as a commensal on or
within the human host for a long time. However, alterations in the host environment
can render C. albicans virulent. In this review, we describe the immunological cross-talk
between C. albicans and the human innate immune system. We give an overview in
form of pairs of human defense strategies including immunological mechanisms as well
as general stressors such as nutrient limitation, pH, fever etc. and the corresponding
fungal response and evasionmechanisms. Furthermore, Computational Systems Biology
approaches to model and investigate these complex interactions are highlighted with
a special focus on game-theoretical methods and agent-based models. An outlook on
interesting questions to be tackled by Systems Biology regarding entangled defense and
evasion mechanisms is given.
Keywords: Candida albicans, human immune system, host-pathogen interaction, computational systems biology,
defense and evasion strategies, immunological cross-talk
1. Introduction
The diploid, polymorphic yeast Candida albicans (Wilson et al., 2009; Kwak et al., 2014; Mech
et al., 2014) is one of the most important human pathogenic fungi (Lu et al., 2014; Vylkova and
Lorenz, 2014; Whittington et al., 2014). This opportunistic ubiquitous fungus (Faro-Trindade and
Brown, 2009; Zipfel et al., 2011; Bain et al., 2012) usually resides as a commensal on the skin and
mucosal surfaces of 30 to 70 % of the human population (Cheng et al., 2012; Jacobsen et al., 2012;
Quintin et al., 2014). As part of the normal humanmicrobiota in the gastrointestinal, oropharyngeal
or urogenital tract (Moyes and Naglik, 2011; Luo et al., 2013; Wellington et al., 2014) C. albicans
can grow, proliferate and coexist within the human host for a long time (Yan et al., 2013) without
causing any symptoms of disease (Moyes and Naglik, 2011; Gow et al., 2012; Mayer et al., 2013).
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C. albicans is highly specialized for the life on or within the
human host (Wilson et al., 2009). The homeostasis between C.
albicans and the human host is kept by the human immune
system (Luo et al., 2013; Yan et al., 2013; Vylkova and Lorenz,
2014) and the normal bacterial flora on mucosal surfaces and
epithelial layers (Mayer et al., 2013; Yan et al., 2013; Mech et al.,
2014). However, alterations in the host environment can render
commensal factors into virulence attributes once the conditions
favor pathogenicity (Moyes and Naglik, 2011; Bain et al., 2012;
Whittington et al., 2014). Thus, there is a subtle balance between
the commensal- and the pathogenic state of C. albicans. This is
testified by a large number of defense mechanisms of the immune
system and evasion mechanisms of C. albicans. Furthermore,
there is evidence for probiotic action of C. albicans, for instance
regarding protection of the vaginal flora (Martin et al., 1999). To
understand this complex interplay, Systems Biology approaches
have shown to be very instrumental (Hummert et al., 2010; Mech
et al., 2014; Tierney et al., 2014). Here we provide a systematic
overview of the host-pathogen interactions to promote this
endeavor.
There are two major types of C. albicans infections in humans
(Filler, 2013; Luo et al., 2013; Mayer et al., 2013). Superficial
mucosal diseases like vaginal or oral candidiasis are extremely
common (Cheng et al., 2012; Filler, 2013; Wellington et al.,
2014). It is estimated that 75 % of all women worldwide suffer
from vulvovaginal candidiasis at least once in their life and 40
to 50 % experience recurrent infections (Wilson et al., 2009;
Mayer et al., 2013). Startlingly vaginal infections often occur
without any sign of immune defect (Jacobsen et al., 2012). While
Candida-associated denture stomatitis is caused in elderly and
edentulous individuals (Moyes and Naglik, 2011; Mayer et al.,
2013) oral and oesophageal candidiasis is particularly common in
HIV-positive individuals (Wilson et al., 2009; Moyes and Naglik,
2011; Jacobsen et al., 2012). Severe mucosal diseases and life-
threatening systemic infections arise in immunocompromised
individuals (Yan et al., 2013; Mech et al., 2014; Wellington et al.,
2014). These invasive infections of the bloodstream and virtually
every organ of the human body (Wilson et al., 2009; Mayer
et al., 2013; Vylkova and Lorenz, 2014) are associated with a
severe morbidity (Faro-Trindade and Brown, 2009; Zipfel et al.,
2011; Cheng et al., 2012; Luo et al., 2013), an unexeptably high
mortality (Zipfel et al., 2011; Filler, 2013; Yan et al., 2013) and
high healthcare costs (Yan et al., 2013; Vialas et al., 2014). As
disseminated hematogenous candidiasis is the 3rd to 4th most
common nosocomial bloodstream infection (Faro-Trindade and
Brown, 2009; Wilson et al., 2009; Vylkova and Lorenz, 2014)
C. albicans is medically as important as many mainstream
bacterial infections including Enterococci like Escherichia coli and
Pseudomonas spp. (Moyes and Naglik, 2011; Zipfel et al., 2011).
It is of particular significance that the human immune system
is able to discriminate between the commensal colonization
and the pathogenic invasion phase of C. albicans (Cheng et al.,
2012; Gow et al., 2012). A robust immune response is therefore
required to protect the host against Candida infection (d’Enfert,
2009; Jacobsen et al., 2012). This immune response can be divided
into physical barriers and immune-barriers of the mucosa (Luo
et al., 2013; Yan et al., 2013). The complexity of possible
host-pathogen-interactions is high, as C. albicans is likely to
encounter different components of the human immune system
(Jacobsen et al., 2012). C. albicans has developed a large number
of strategies to evade or undermine the antimicrobial defense
responses of the host immune system (Collette and Lorenz,
2011; Zipfel et al., 2011; Lopez, 2013; Luo et al., 2013). These
strategies may allow the fungus to control the host immune
attack, to cross tissue barriers and to disseminate in the human
body (Zipfel et al., 2011; Jacobsen et al., 2012; Luo et al.,
2013).
In this review, we describe the immunological cross-talk
between C. albicans and the human immune system. We follow
the trail of infection: starting from phenotypic adaptations and
morphogenesis, Candida encounters stress by the host and
its infected tissue environment including nutrient limitation,
temperature and pH stress. Furthermore, the host immune
system responds with the innate immune attack as the
immediately acting primary line of defense against systemic
fungal infections (Cheng et al., 2012; Lopez, 2013). That line
of host defense mainly relies on humoral complement actions,
antimicrobial peptides and the cellular response mediated by
phagocytes, especially by neutrophils and macrophages (Bain
et al., 2012; Cheng et al., 2012; Jiménez-López and Lorenz, 2013).
Because of the complex immune response we here focus
on the innate immune system. The adaptive immune system
contributes with many additional mechanisms (Curtis and Way,
2009; Korn et al., 2009; Hamad, 2012) which are beyond the
scope of this review. For a review on the crosstalk between innate
and adaptive immune-response and the role of dendritic cells see
Hamad (2012). Here, we start to give an overview of the crosstalk
of human defense mechanisms and the corresponding fungal
evasion mechanisms. As the total amount of such mechanisms
is enormous, the list cannot be exhaustive.
A number of different Systems Biology approaches exist to
model and simulate host pathogen interactions, e.g., Boolean
modeling (Naseem et al., 2012; Schlatter et al., 2012) and reverse
engineering (Tierney et al., 2012). However, no matter which
strategy is chosen, there is always a game of life and death
involved and hence game theoretical approaches and agent-based
modeling are particularly powerful and thus reviewed here. These
approaches are useful to depict the highly complex and dynamic
host-pathogen interactions and can help to gain further insights
into the underlying processes of C. albicans infections.
2. Host Defense and Corresponding Fungal
Evasion Strategies
As a commensal as well as an invading pathogen C. albicans faces
stressors of the host environment. Those stress sources include
changes in nutrient availability, pH, osmolarity, temperature, or
attack by the cells of the immune system (Wilson et al., 2009).
C. albicans has a robust stress response mediated by humoral
components as well as rapid alterations in gene expression of
stress-responsive regulatory pathways which allow C. albicans to
respond to changes of environmental stimuli (Wilson et al., 2009;
Mayer et al., 2013).
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2.1. Stress Induced by the Human Host and its
Environment
As a commensal C. albicans competes with all the probiotic
microorganisms of the host’s microflora for nutrients (Brunke
and Hube, 2013; Whittington et al., 2014). Even though the gut is
relatively rich in nutrients, those nutrients are quickly absorbed
by the microbial flora and the epithelial cells (Whittington et al.,
2014). In other host niches nutrients are limited by the host
and usually not available to pathogens (see Table 1). However,
C. albicans is metabolically flexible and uses nutrient acquisition
mechanisms such as sequestration of iron and zinc to survive and
grow in the many different and changing host niches such as the
gastrointestinal, oropharyngeal or urogenital tract (Brunke and
Hube, 2013; Whittington et al., 2014).
One of those mechanisms is the release of secreted aspartic
proteases (Saps) by C. albicans. Saps can destroy host tissue and
liberate oligopeptides and amino acids. These liberated carbon
sources are then taken up by C. albicans via oligopeptide and
amino acid transporters (Brunke and Hube, 2013). Adding to
the metabolic flexibility C. albicans has no known auxotrophies
and can metabolize a broad range of sugars and all amino acids
(Brunke and Hube, 2013; Lopez, 2013).
When facing nutrient starvation or phagocytosis C. albicans
shows responses that are similar in the two cases, switching
from the glycolytic pathway to the glyoxylate cycle and
gluconeogenesis (Faro-Trindade and Brown, 2009; Lopez, 2013;
Vylkova and Lorenz, 2014) which is absent from humans. This
metabolic shift enables C. albicans to metabolize alternative,
less favored carbon sources (De Figueiredo et al., 2008; Faro-
Trindade and Brown, 2009). Next to amino acids and lipids,
lactate produced by tissues and bacteria in the gut serves as one
potential carbon source (Lopez, 2013). The growth on alternative
carbon sources can cause substantial changes in the cell wall of
C. albicans even when the morphology of the cell is otherwise
unaltered (Gow et al., 2012). This influences the recognition
by phagocytes as well as drug- and stress-resistance of the cell
(Vylkova and Lorenz, 2014). C. albicans cells grown on lactate
have been shown to be more resistant to osmotic, envelope and
antifungal stresses and to be more adherent. They even elicit
lower levels of proinflammatory cytokines from monocytic cells
and once phagocytosed aremore harmful tomacrophages thanC.
albicans cells grown on glucose. The exposure to non-preferred
carbon sources therefore benefits C. albicans, especially in their
interactions with macrophages (Lopez, 2013). This fact may be
helpful for metabolic therapy strategies, as supplementing certain
nutrients in the infection locus may render C. albicans more
vulnerable to the host defense.
Another important defense mechanism in the host’s
“nutritional immunity” is the active sequestration of metals
(Brunke and Hube, 2013). The most important micro nutrients
that are prerequisite for C. albicans infection are iron, zinc,
manganese and copper (Brunke and Hube, 2013; Mayer et al.,
2013). Both the pathogenic fungus and its host have evolved
mechanisms to acquire and restrict access to these metals (Mayer
et al., 2013).
The human host is severely restricting the availability of
iron to pathogens by keeping the iron levels of the blood and
the tissue environment low (Brunke and Hube, 2013). This is
achieved by storing iron in iron-binding proteins like ferritin,
lactoferrin, hemoglobin and transferrin which are usually not
accessible to pathogenic microbes (Faro-Trindade and Brown,
2009; Jacobsen et al., 2012). C. albicans on the other side has
developed a plethora of iron acquisition systems (Brunke and
Hube, 2013) including a reductive system, a siderophore uptake
system and a heme-iron uptake system (Mayer et al., 2013). C.
albicans can utilize its siderophore uptake system via Sit1/Arn1
(siderophore iron transport 1) to steal iron from siderophores
produced by other microorganisms without producing its own
siderophores (Brunke and Hube, 2013; Mayer et al., 2013). C.
albicans can further bind host ferritin with the hyphae-associated
adhesion and invasion protein Als3 (agglutinin-like sequence 3)
(Jacobsen et al., 2012; Brunke andHube, 2013;Mayer et al., 2013).
The reductive system, with its large gene families of reductases,
oxidases and iron permeases (Brunke and Hube, 2013), then
TABLE 1 | Pairs of defense and evasion strategies—adapting to the host environment.
Human host C. albicans
Limiting nutrient availability to pathogens Release of secreted aspartic proteases (Saps) to liberate oligopeptides and amino acids from tissues
Nutrient starvation e.g., in phagocytes Switching from the glycolytic pathway to the glyoxylate cycle and gluconeogenesis to metabolize alternative carbon sources
Active sequestration of iron Iron acquisition through: a reductive system, a siderophore uptake system and a heme-iron uptake system
Active sequestration of zinc Zinc acquisition via a zincophore system
Inducing pH-stress Sense and adapt to environmental pH (Pra1); modulate extracellular pH by actively alkalizing the surrounding environment
Inducing thermal stress like fever Heat shock response mediated by heat shock proteins and trehalose accumulation
Inducing osmotic stress Outer cell wall structure as protection from osmotic pressure; intracellular accumulation of glycerol to counteract the loss of
water
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mediates the iron acquisition from host ferritin, transferrin or if
available free iron from the environment. C. albicans can also use
iron from host hemoglobin and hemoproteins by first expressing
haemolysins that disrupt red blood cells (Brunke andHube, 2013;
Mayer et al., 2013). Subsequently the iron acquisition is mediated
by the heme-receptor gene family members RBT5, RBT51, CSA1,
CSA2, and PGA7 (RBT6) (Mayer et al., 2013).
Zinc as a central cofactor for many proteins is an abundant
metal in most living organisms (Brunke and Hube, 2013).
The sequestration of zinc is therefore a potent antifungal
mechanism of the host during infections and is mediated by
calprotectin (Faro-Trindade and Brown, 2009; Brunke andHube,
2013). C. albicans can acquire zinc via a “zincophore” system
using pH-regulated antigen 1 (Pra1) (Brunke and Hube, 2013).
Secreted Pra1 acts as a zincophor, similar to iron-carrying
siderophores (Brunke and Hube, 2013), binds extracellular zinc
and reassociates with the fungal cell (Mayer et al., 2013). This
reassociation is mediated by the zinc transporter Zrt1 (Mayer
et al., 2013).
Though copper and manganese are essential for fungal
growth, the mechanisms by which C. albicans acquires them are
less well understood. There is a putative manganese transporter,
Ccc1, and a putative copper transporter, Ctr1, but their roles in
C. albicans virulence have not yet been determined (Mayer et al.,
2013).
Next to nutritional stress, pH-stress is of fundamental
importance to C. albicans. Depending on the host niche C.
albicans encounters many different pH levels. While the pH
of human blood and tissues is slightly alkaline, the pH of the
digestive tract ranges from very acidic to more alkaline. pH-
stress can also occur in the urogenital tract as well as in the
phagolysosome, where pH is very acidic, once C. albicans is
phagocytosed by cells of the innate immune system. However, C.
albicans is able to adapt to significant changes in its surrounding
pH. The two C. albicans cell wall proteins Phr1 (pH responsive 1)
(required for systemic infections) and Phr2 (essential for
infections of the vagina) are important for adaptation to changing
pH. Astonishingly C. albicans is not only able to sense and
adapt to environmental pH but also to modulate extracellular
pH by actively alkalizing its surrounding environment (Mayer
et al., 2013). C. albicans can release ammonia derived from
amino acid degradation to raise extracellular pH (Lopez, 2013).
This is of special importance after phagocytosis as it promotes
the neutralization of the phagosomal pH, inducing hyphal
morphogenesis and thereby fosters the escape of the pathogen
from macrophages (Vylkova and Lorenz, 2014).
Thermal stress like fever and cold leads to a heat shock
response mediated by heat shock proteins and trehalose
accumulation in C. albicans. These heat shock proteins and
trehalose act as “molecular- and chemical- chaperons” by
preventing deleterious protein unfolding and aggregation (Mayer
et al., 2013).
The outer layer of C. albicans’ cell wall not only defines
the cell shape and provides an efficient barrier against immune
reactions but also protects the fungus from osmotic pressure (Luo
et al., 2013). A further osmotic stress response is the intracellular
accumulation of glycerol to counteract the loss of water due to an
outward-directed chemical gradient. The glycerol biosynthesis is
mediated by the glycerol 3-phosphatase (Gpp1) and the glycerol
3-phosphate dehydrogenase 2 (Gpd2) (Mayer et al., 2013).
2.2. The Human Innate Immun System
Zipfel et al. (2011) started a list of immune evasion and tissue
invasion mechanisms including complement evasion, evasion of
cellular response and tissue invasion mechanisms by C. albicans
which we include and further augment in Table 2. Several of
the mechanisms listed in Table 2 have been modeled by Systems
Biology approaches (see Section 3).
C. albicans can switch readily between yeast, hyphal and
pseudohyphal growth and back (Brunke and Hube, 2013; Kwak
et al., 2014; Lu et al., 2014). Both the yeast and hyphal forms
of the fungus are required for biofilm formation as well as full
virulence (Lopez, 2013; Yan et al., 2013). Mutants locked in
one morphology are avirulent and show a significantly reduced
growth performance in biofilm formation (Baillie and Douglas,
1999; Lopez, 2013; Yan et al., 2013).
Biofilms are three-dimensional microbial communities in an
extracellular matrix adhering to mucosal or artificial surfaces
(Ganguly and Mitchell, 2011) for example biomaterials used
for implants like stents and catheters. While the C. albicans
biofilms on abiotic surfaces consist of yeast and filamentous cells
of the fungus (Baillie and Douglas, 1999; Ramage et al., 2006;
Ganguly and Mitchell, 2011) the in vivo C. albicans biofilms are
polymicrobial with an extracellular matrix layer that contains
host immune cells (Ganguly and Mitchell, 2011). C. albicans
biofilms protect the pathogen from host immune attacks and
antifungal drugs (Baillie and Douglas, 1998; Seneviratne et al.,
2008; Yan et al., 2013). Especially C. albicans abiotic surface
biofilms are associated with increased drug resistance (Baillie
and Douglas, 1998; Ganguly and Mitchell, 2011). This antifungal
resistance increases with biofilm maturation (Chandra et al.,
2001). There are indications that C. albicans biofilms are even
resistant to killing by neutrophils (Ganguly and Mitchell, 2011;
Mayer et al., 2013) and do not trigger the production of reactive
oxygen species (ROS) (Mayer et al., 2013). Reviews on the
regulatory control of C. albicans within biofilms can be found in
Nobile and Mitchell (2006) and Finkel and Mitchell (2011). For a
review on C. albicans biofilms on mucosal surfaces see Ganguly
and Mitchell (2011).
After invading host tissues C. albicans encounters an
early defense line: the innate immune system. The innate
immune system maintains host homeostasis by recognizing and
cleaning modified or damaged host cells. It directly attacks and
limits the growth of invading microbes without inflammatory
reactions. This defense is mediated through three major effector
mechanisms: antimicrobial peptides, the complement system and
immune cells that recognize and respond to foreign microbes
(Zipfel et al., 2011).
The initial interaction of C. albicans with the human immune
system is with epithelial cells of the mucosa (Moyes and Naglik,
2011; Luo et al., 2013) that act as physical barriers. The fungus
is able to invade the human host tissues via two routes: induced
endocytosis and active penetration (Mech et al., 2014). The
passive uptake is a host driven process, mediated by C. albicans
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TABLE 2 | Pairs of defense and evasion strategies—C. albicans and the human innate immune system.
Human host C. albicans
EPITHELIAL RESPONSE
Physical barrier Active penetration by thigmotropism, elongating hyphae and production of lytic enzymes;
induction of endocytosis; degradation of extracellular matrix component by recruiting
human plasminogen to the yeast surface and secretion of lytic enzymes
Chemical barrier in form of secreted antimicrobial peptides and
degradative enzymes
Respond to β-defensin activity via the high-osmolarity glycerol (HOG) pathway; secretion
of Sap9 and a Msb2 fragment
The host uses C. albicans’ pumps to get antimicrobial peptides into the
pathogen
Uses multi-drug resistance pumps such as Flu1 to transport antimicrobial peptides out of
the pathogen
COMPLEMENT RESPONSE
Complement systems barrier Acquiring human complement regulators to the cell surface; secretion of complement
inhibitors to block C3 complement activation; production of proteases (Saps) to degrade
host complement proteins
CELLULAR RESPONSE
PRRs recognition barrier via dectin-1, dectin-2, etc. Surface mannans shield β-glucan from recognition by dectin-1 to avoiding phagocytosis;
release of soluble decoys to evade host immune responses
Barrier in form of pro- and anti-inflammatory cytokines and chemokines
production
Inhibition of proinflammatory IL-17 production by altering the host tryptophan metabolism;
induction of anti-inflammatory cytokine release
Inhibition of C. albicans yeast-to-hyphal transition by neutrophils No known evasion mechanism
Cellular ET formation by neutrophils and macrophages No known evasion mechanism
Phagocytosis Biofilm formation; inhibition of phagolysosome formation; neutralization of phagosomal pH
inside macrophages; induction of hyphal morphogenesis and escape from the immune
cell in macrophages and natural killer cells; pyroptosis / macrophage cell death
Oxidative and nitrosative stress induced by neutrophils and macrophages Inhibition of ROS generation by macrophages through an unknown mechanism; secretion
of Sod enzymes, catalases, glutathione peroxidases and thioredoxin to detoxify
extracellular ROS; accumulation of trehalose against oxidative stress; production of
intracellular flavohemoglobin enzymes against nitrosative stress; biofilm formation
surface proteins Als3 and Hgc1 (hypha-specific expression and
relatedness to G1 cyclins 1) which bind to epithelial cell E-
cadherin (Wilson et al., 2009). Active penetration on the other
hand does not rely on the host but exclusively on fungal attributes
including physical pressure applied by the advancing hyphal
tip, thigmotropism and the secretion of extracellular hydrolases
like Saps, class B phospholipase (Plb) and lipase (Lip) families
(Wilson et al., 2009; Mayer et al., 2013).
Epithelial cells not only provide a physical barrier but also
have an active, integral role in mucosal protection against
C. albicans by discriminating between the commensal and
pathogenic form of the fungus. Next to the NF-κB pathway,
Moyes and Naglik (2011) identified the MAPK signaling as
an important mechanism in the epithelial cell responses to
Candida infections. The presence of C. albicans yeast or
hyphae triggers the NF-κB signaling and an early response
of the MAPK activation through ERK1/2 and JNK signaling
which induces the c-Jun activity. When a sufficient fungal
hyphal burden is present and the threshold level of activation
is reached, a second prolonged, late response is induced,
activating MAPK regulation via the MAPK phosphatase MKP1
through ERK1/2 and p38 signaling. This in turn induces c-
Fos activity resulting in the production of cytokines with a
proinflammatory profile like interleukin 1α/β (IL-1α/β), IL-
6, G-CSF, GM-CSF, and TNF-α as well as the chemokines
RANTES, IL-8, and CCL20 (Steele and Fidel, 2002; Moyes and
Naglik, 2011; Cheng et al., 2012). Chin et al. (2014) showed
that the post-infection regulation of cytokines for IL-2, IL-6,
TNF-α, TNF-β are organ-specific (i.e., kidney, spleen, brain).
The secretion of proinflammatory molecules results in the
recruitment, differentiation, and activation of various immune
cells (Moyes and Naglik, 2011; Cheng et al., 2012). Especially
important for an early immune response of mucosal surfaces
to C. albicans infection is IL-22. This cytokine is produced
by innate and adaptive immune cells (De Luca et al., 2010;
Zenewicz and Flavell, 2011). A heterodimeric receptor consisting
of IL-22R and IL-10Rb recognizes IL-22 (Eyerich et al., 2011;
Sonnenberg et al., 2011; Zenewicz and Flavell, 2011). As the
expression of IL-22R is mainly confined to epithelial cells, the
signaling is specific to tissues (Eyerich et al., 2011; Zenewicz
and Flavell, 2011). IL-22 has both pro- and anti-inflammatory
functions (De Luca et al., 2010) and stimulates the proliferation
(Kagami et al., 2010; Zenewicz and Flavell, 2011) and together
with IL-17 the production of antimicrobial peptides by epithelial
cells (De Luca et al., 2010; Kagami et al., 2010; Eyerich et al.,
2011). The IL-23/IL-22 axis controls the initial fungal growth
and tissue homeostasis (De Luca et al., 2010; Zelante et al.,
2011). The combinatorial secretion of IL-22 and TNF-α by Th22
cells increases the induction and secretion of the complement
factors C1r and C1s, antimicrobial chemokines and antimicrobial
peptides (Eyerich et al., 2011).
2.2.1. Antimicrobial Peptides
Two important groups of antimicrobial peptides are α- and
β-defensins. The α-defensins group consists of four cationic
peptides, HNP1 to HNP4, that are found in the azurophilic
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granules of human neutrophils. The group of β-defensins is
primarily expressed by epithelial cells and includes human β-
defensins 2 and 3 (hBD-2 and hBD-3), that have significant
antifungal activity. They can be induced by a variety of agents,
including TLR agonists, as well as monocyte- and macrophage-
derived factors, such as IL-1 (Faro-Trindade and Brown, 2009).
The two groups of α- and β-defensins can be distinguished based
on their arrangement of disulfide linkages (Faro-Trindade and
Brown, 2009; Yan et al., 2013). Both defensin groups target C.
albicans cell membranes and cause nonlytic permeabilization and
release of cellular ATP (Faro-Trindade and Brown, 2009). The
damage imposed on C. albicans by hBD-2 and hBD-3 shares
similarities with that caused by osmotic and oxidative stress. C.
albicans in turn can respond to these hBD-2 and hBD-3 injuries
via the high-osmolarity glycerol (HOG) pathway and rescue cells
from β-defensin activity (Yan et al., 2013). Defensins can also act
as chemoattractants for monocytes, dendritic cells, and selected
lymphocytes (Faro-Trindade and Brown, 2009).
Another important antimicrobial peptide is LL-37, that kills
C. albicans by fragmenting the cellular membrane of the
fungus, leading to eﬄux of molecules like ATP and proteins
(Den Hertog et al., 2005; Faro-Trindade and Brown, 2009). LL-37
can further act as a chemoattractant for neutrophils, monocytes
and lymphocytes, induce histamine release from mast cells, alter
the transcriptional response in macrophages and play a role in
wound repair (Faro-Trindade and Brown, 2009). The peptide
is produced by the proteolytic cleavage of cathelicidin (hCAP-
18) (Den Hertog et al., 2005; Faro-Trindade and Brown, 2009).
The hCAP-18 produced in neutrophils, and other cells including
monocytes, natural killer cells, lymphocytes and a variety of
epithelial cells, has antimicrobial activity itself (Faro-Trindade
and Brown, 2009).
A family of cationic serine proteases called serprocidins also
possess antimicrobial activity. Members of this family are stored
within neutrophil granules and include protease-3, cathepsin
G, and elastase. Those proteins are involved in many cellular
processes including the cleavage of hCAP-18, cellular activation,
as well as chemotaxis (Faro-Trindade and Brown, 2009).
Another example of an antimicrobial enzyme is lysozyme
which targets the cell membrane of C. albicans. Lysozyme is
expressed by a variety of phagocytes, including granulocytes,
monocytes as well as macrophages and can be found at high levels
in various tissues and secretions such as saliva. Its fungicidal
activity is thought to occur through enzymatic hydrolysis of N-
glycosidic bonds within the fungal cell wall and injury to the cell
membrane (Faro-Trindade and Brown, 2009).
It is worth noting that the host makes use of C. albicans’
polyamine influx transporters to get some antimicrobial peptides
like histatin 5 into the pathogen. C. albicans in turn, uses multi-
drug resistance pumps such as the fungal polyamine eﬄux
transporter Flu1 to transport those antimicrobial peptides out
again and thus reduce their toxicity (Li et al., 2013). C. albicans
is also able to cleave histatin 5 with its protease Sap9 (Szafranski-
Schneider et al., 2012).
Another mechanism by which C. albicans deals with
antimicrobial peptides is the shedding of a large glycosylated
fragment of Msb2. C. albicans’Msb2 stabilizes the fungal cell wall
and inactivates histatin 5 and LL-37 (Szafranski-Schneider et al.,
2012; Swidergall et al., 2013) as well as human α- and β-defensins
(Swidergall et al., 2013).
2.2.2. Complement System
The complement system is highly efficient in recognizing and
eliminating infectious pathogens while its activation is tightly
regulated in time and space. For reviews about the interactions of
C. albicans with the human complement system see Zipfel et al.
(2011); Cheng et al. (2012); Zipfel et al. (2013); Luo et al. (2013).
For complement evasion C. albicans acquires several human
complement regulators, e.g., C4BP (complement component 4b-
binding protein), factor H, FHL-1 (four and a half LIM domains
protein 1), plasminogen and vitronectin, to its cell surface to
inhibit the actions of the complement system (Luo et al., 2013).
Factor H is bound by four C. albicans proteins: phosphoglycerate
mutase (Gpm1), Pra1, the high-affinity glucose transporter 1
(Hgt1p) andGpd2 (Luo et al., 2013; Zipfel et al., 2013).C. albicans
Pra1 and Hgt1p also bind C4BP. There are eleven C. albicans
proteins that bind host plasminogen: Gpm1, enolase, Tsa1, Cta1
(catalase 1), Tdh3 (triose phosphate dehydrogenase 3), Tef1
(translation elongation factor 1-alpha), Pgk1 (phosphoglycerate
kinase 1), Adh1 (alcohol dehydrogenase 1), Fba1 (fructose-
bisphosphate aldolase), Pra1 and Gpd2 (Zipfel et al., 2013) and
three C. albicans proteins which bind human FHL-1: Gpm1,
Pra1 and Gpd2 (Luo et al., 2013). Human plasminogen bound
on C. albicans’ cells, can be activated to proteolytically active
plasmin that cleaves host fibrinogen thereby contributing to
the tissue invasion of C. albicans cells into epithelia cell layers
(Zipfel et al., 2011). C. albicans further expresses ανβ3 integrin-
like protein that acquires host vitronectin to the fungal cell
surface. This in turn inhibits the formation of the terminal
complement complex (Luo et al., 2013). C. albicans can
furthermore secrete aspartyl proteases Sap1, Sap2, and Sap3 that
degrade the host complement proteins C3b, C4b and C5 (Gropp
et al., 2009; Luo et al., 2013). The expression of endogenous
complement inhibitors like secreted Pra1 which binds the central
complement component C3 in solution is another mechanism
by C. albicans to block C3 and complement activation (Zipfel
et al., 2011). Secreted Pra1 also blocks the human integrin
receptors CR3 and CR4, expressed by human leukocytes,
granulocytes, macrophage and natural killer cells thereby
inhibiting recognition, phagocytosis and cell-mediated killing
(Luo et al., 2013).
Phagocytes respond to pathogens by recognizing opsonins
and pathogen-associated molecular pattern (PAMPs) using
surface expressed pattern recognition receptors (PRRs) (Jacobsen
et al., 2012; Lopez, 2013; Luo et al., 2013). As the cell wall
of C. albicans contains carbohydrates and cell wall proteins
that are not present in the human body, it represents an ideal
immunological target (Gow et al., 2012). Exhaustive reviews on
C. albicans’ cell wall architecture and its recognition have been
published by Netea et al. (2008); Netea and Maródi (2010);
Moyes and Naglik (2011); Gow et al. (2012). The most important
C. albicans PAMPs are its cell wall carbohydrates: mannan (as
mannosylated proteins), β-glucan, and chitin (Lopez, 2013).
One mechanism used by C. albicans to evade the cellular
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response by phagocytes is to shield these β-glucans with surface
mannans upon hyphal growth to avoid phagocytosis (Luo et al.,
2013). The receptor ligation of PRRs with PAMPs activates
resident phagocytes and leads to synthesis and secretion of
cytokines and lipid mediators. One evasion mechanism by
C. albicans is the induction of an anti-inflammatory cytokine
release by favoring toll-like receptor (TLR) 2 instead of TLR4
recognition (Zipfel et al., 2011). C. albicans is further able
to inhibit the proinflammatory IL-17 production by altering
the host tryptophan metabolism. This metabolism is regulated
by two distinct enzymes: Indoleamine 2,3- dioxygenase (IDO)
and tryptophan hydroxylase. By inhibiting IDO expression, C.
albicans can shift the tryptophan metabolism, leading to fewer
kynurenines and more 5-hydroxytryptophan metabolites. The
increased 5-hydroxytryptophan levels subsequently inhibit the
host IL-17 production (Cheng et al., 2010, 2012). A similar
mechanism is used by cancer cells (Uyttenhove et al., 2003)
and has been described by a mathematical model (Stavrum
et al., 2013). For a detailed explanation of the recognition of
C. albicans PAMPs and the C. albicans evasion strategies from
epithelial cell defense see Netea et al. (2008); Netea and Maródi
(2010); Moyes and Naglik (2011); Gow et al. (2012); Mech et al.
(2014).
2.2.3. Phagocytes
While viral infections are primarily fought by T-cells in particular
T-killer-cells, defense against fungi resembles bacteria defense in
mobilizing neutrophils and macrophages.
Invading and disseminating C. albicans cells are faced with
phagocytic cells (Kumar and Sharma, 2010; Zipfel et al., 2011;
Jacobsen et al., 2012). Phagocytes, especially neutrophils and
macrophages are of major importance for the host defense
against mucosal and disseminated candidiasis (Cheng et al.,
2012; Krysan et al., 2014; Quintin et al., 2014). These immune
cells most effectively control and clear C. albicans infections
by killing C. albicans cells intracellularly and extracellularly
(Cheng et al., 2012). C. albicans on the other hand has evolved
several mechanisms to control and evade the antimicrobial
activity of local and newly attracted phagocytic cells by inhibiting
recognition, trafficking, and effector release, thus overcoming
several important stresses (Lopez, 2013; Luo et al., 2013).
Neutrophils are the prevalent immune cell type in anti-
Candida immunity (Moyes and Naglik, 2011; Luo et al., 2013).
During C. albicans infection, neutrophils migrate to sites of
infection and release one or more chemotactic factors (Luo et al.,
2013). After recognition of C. albicans cells through dectin-
1 (recognizes β-1,3 glucan), dectin-2 (recognizes mannan),
TLR2 (recognizes phospholipomannan), TLR4 (recognizes O-
mannan), andmannose receptor (recognizes N-mannan) (Moyes
and Naglik, 2011) neutrophils induce epithelial cell mediated
protection against C. albicans infections and can directly kill
Candida cells (Moyes and Naglik, 2011). The presence of
neutrophils further inhibits C. albicans growth, including the
yeast-to-hyphal transition (Jacobsen et al., 2012). These immune
cells preferentially target C. albicans hyphae but kill yeast and
hyphal forms of C. albicans at the same rate (Jacobsen et al., 2012;
Tyc et al., 2014). Neutrophils rely on a range of antimicrobial
effector mechanisms including oxidative burst, cytokine release,
phagocytosis, neutrophil extracellular traps (NETs), release of
granule enzymes as well as antimicrobial peptides to kill the
fungus (Luo et al., 2013). Additionally they may differentiate into
discrete subsets defined by distinct phenotypic and functional
profiles (Scapini and Cassatella, 2014).
Another important immune cell type in anti-Candida
immunity are macrophages (Jiménez-López and Lorenz, 2013;
Krysan et al., 2014; Liu et al., 2014). These dynamic cells are
distributed in various tissues and are part of the first line of
host defense (Brunke and Hube, 2013; De Lima et al., 2014;
Liu et al., 2014). Macrophages are of particular importance
as they can both limit C. albicans burden early in infection
and recruit and activate other immune effector cells (Krysan
et al., 2014). Macrophages produce a variety of pro- and anti-
inflammatory cytokines and chemokines in response to C.
albicans (Jacobsen et al., 2012; Krysan et al., 2014). Particularly,C.
albicans hyphae formation is a strong trigger for the production
of IL-1β (Krysan et al., 2014) thereby helping to orchestrate the
immune responses of the host (Jacobsen et al., 2012; Brunke and
Hube, 2013). Cheng et al. (2011) showed that the development
of hyphae during tissue invasion triggers the recognition by
macrophages via the dectin-1/inflammasome pathway, leading
to IL-1β production and thus T helper cell 17 (Th17 cell)
activation. For a review on inflammasome activation see van de
Veerdonk et al. (2015). Macrophages damage or directly kill
C. albicans (Krysan et al., 2014) utilizing a combination of
oxidative and nonoxidative microbicidal mechanisms including
the production of antimicrobial peptides and degradative
enzymes, the generation of ROS and nitric oxide synthase
(iNOS), phagocytosis andmacrophage extracellular traps (METs)
(Liu et al., 2014). During phagocytosis macrophages readily
ingest the round yeast form of C. albicans as well as relatively
short filaments (Jacobsen et al., 2012; Brunke and Hube, 2013;
Krysan et al., 2014). The fungus on the other side has developed
several defense strategies to escape from macrophages with a
significant cytotoxic effect on the immune cell, e.g., pyroptosis
(Krysan et al., 2014).
Natural killer cells are innate lymphocytes with a potent
cytotoxic activity. They usually are of major importance
in viral infections and anti-tumor immunity (Voigt, 2013).
The role of natural killer cells in host defense against C.
albicans infection strongly differs depending on the state of
host defense. While natural killer cells are an essential and
non-redundant component of anti-C. albicans host defense in
immunosuppressed hosts with defective T- and B-lymphocyte
immunity they can contribute to hyperinflammation in
immunocompetent hosts (Quintin et al., 2014). Natural
killer cells modulate the immune responses by secreting
cytokines which in turn recruit and activate other innate
immune cells. Natural killer cells are also able to phagocytose
C. albicans cells. However, in contrast to the professional
phagocytic activity of neutrophils, this does not inhibit the
further elongation of C. albicans filaments and leads to
the destruction of the natural killer cell (Voigt, 2013). It
was therefore proposed by Voigt (2013) that these immune
cells contribute to the protective immunity against C.
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albicans by recruiting other immune cells and enhancing
proinflammatory activities without efficiently restricting the
fungus.
Another important innate immune cell type for the C.
albicans defense are dendritic cells. They are professional
antigen-presenting cells which coordinate the immune response
and link innate and adaptive immunity (Cheng et al., 2012;
Ramirez-Ortiz and Means, 2012). Dendritic cells reside and
patrol in the skin and mucosal surface and ingest Candida
once tissues are invaded (d’Ostiani et al., 2000; Cheng et al.,
2012). These immune cells use C-type lectin pattern recognition
receptors like Dectin-1, Dectin-2 and DC-Sign to recognize
the fungus. Dendritic cells phagocytose both yeast and hyphal
C. albicans cells but kill yeast cells more efficiently (Jacobsen
et al., 2012). After processing C. albicans they present Candida-
specific antigens via major histocompatibility complex class II
molecules (Cheng et al., 2012). Dendritic cells therefore have
a bridging effect between the innate and adaptive antifungal
responses. They are able to discriminate between yeast- and
hyphal- forms of C. albicans (d’Ostiani et al., 2000; Cheng
et al., 2012) and induce different T helper cell differentiation
depending on the morphology of phagocytosed C. albicans
cells (d’Ostiani et al., 2000; Cheng et al., 2012; Jacobsen et al.,
2012). While yeast cells stimulate the priming of Th1 cells,
the ingestion of hyphae inhibits IL-12 and Th1 differentiation,
favoring Th2 cell differentiation (Cheng et al., 2012). The Th1
and Th17 cell responses are thought to be beneficial for the host
(Jacobsen et al., 2012). The different responses of dendritic cells
to yeast and hyphae morphologies may thus strongly influence
the clinical course of infection (Hamad, 2012; Jacobsen et al.,
2012).
2.2.4. Inside the Phagosome
Phagocytosis is depending on the glycosylation status of the C.
albicans cell wall, the morphology of the fungus, the hyphal
length, orientation and contact of the hyphae relative to the
phagocyte as well as the immune cell types and their state of
activation (Whittington et al., 2014). C. albicans in turn has
developed mechanisms to resist phagocytic killing by escaping
and even killing some phagocytic cell types (Faro-Trindade
and Brown, 2009; Dementhon et al., 2012; Luo et al., 2013;
Vylkova and Lorenz, 2014; Wellington et al., 2014). Several
phagocytes can efficiently ingest C. albicans yeast cells and short
hyphae (Jacobsen et al., 2012; Smith and May, 2013; Whittington
et al., 2014). Accordingly, a natural evasion strategy is to form
long hyphae because they can not be phagocytosed for simple
geometrical reasons. This is analogous to needle-shaped micro-
particles which can not be engulfed either. Without intervention
by the phagocytosed fungus, the phagosome matures via a
series of fusion and fission events with the lysosome into
the phagolysosome (Cheng et al., 2012; Brunke and Hube,
2013). However, early upon phagocytosis C. albicans is able to
alter intracellular membrane trafficking within the phagosome
by inhibiting phagosome maturation (Cheng et al., 2012;
Dementhon et al., 2012; Vylkova and Lorenz, 2014). Inside
the hostile environment of the phagolysosome C. albicans cells
are killed and degraded by nutrient starvation, low pH levels,
hydrolytic enzymes, antimicrobial peptides, ROS and reactive
nitrogen species (NOS) (Faro-Trindade and Brown, 2009; Zipfel
et al., 2011; Cheng et al., 2012; Luo et al., 2013; Mayer et al.,
2013).
While neutrophils can block hyphal development (Faro-
Trindade and Brown, 2009), C. albicans cells are able to
generate hyphae within the phagolysosome of dendritic cells and
macrophages allowing the fungus in some cases to kill and escape
from those phagocytes (Faro-Trindade and Brown, 2009; Luo
et al., 2013). Hyphal formation is depending on the pH-level
(Faro-Trindade and Brown, 2009). While the acidic pH inside
the phagosome should inhibit germination C. albicans is able to
modulate the phagosomal milieu (Vylkova and Lorenz, 2014). C.
albicans can rapidly alkalize the phagosomal environment via the
arginine biosynthetic pathway (Lopez, 2013; Vylkova and Lorenz,
2014). Neutralization of the pH via the extrusion of ammonia
presumably derived from the amino acid, results in the auto-
induction of hyphal formation (Bain et al., 2012; Vylkova and
Lorenz, 2014).
Some macrophages are able to withstand the stress of
elongating C. albicans filaments without apparent loss
of integrity (Krysan et al., 2014). In other macrophages,
however, the C. albicans hyphal formation can provoke
pyroptosis by activating the NLRP3 (NOD-like receptor
family, pyrin domain containing 3) inflammasome and
caspase-1. This proinflammatory, inflammasome-mediated
programmed cell death pathway leads to the macrophage
lysis and production of IL-1β and IL-18, allowing C. albicans
to escape the hostile environment of the phagocyte. Early
upon phagocytosis the majority of macrophage lysis is
mediated by pyroptosis (Uwamahoro et al., 2014; Wellington
et al., 2014). Later, a second macrophage killing phase,
independent and distinct from pyroptosis, is initiated by
C. albicans which depends on robust hyphal formation. As
pyroptosis has a protective role in infections with bacterial
pathogens by increasing inflammatory responses this might
also be the case in C. albicans infections (Uwamahoro et al.,
2014).
In a minority of cases phagocytosed C. albicans cells can
escape from macrophages through non-lytic expulsion (Brunke
and Hube, 2013; Lopez, 2013), also called exocytosis (Bain
et al., 2012) or vomitosis (Whittington et al., 2014). This rare
event is reported to occur at a low frequency but repeatedly in
various experimental conditions (Bain et al., 2012). Although
the underlying mechanisms are unknown (Lopez, 2013) it is
observed that both, the macrophage as well as the C. albicans
cell, remain intact and viable during phagocytosis and subsequent
expulsion. This means the macrophage cell retains its phagocytic
ability and is able to undergo mitosis as shown in Bain et al.
(2012) while the C. albicans cell can perform hyphae elongation
at normal rates. As non-lytic expulsion avoids lysis of the
macrophage but also of the C. albicans cell this process may
benefit both cell types (Bain et al., 2012). It is therefore not trivial
to account the process as strategy to either macrophages or C.
albicans.
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2.2.5. Oxidative and Nitrosative Stress and its
Detoxification
Phagocytes can produce oxidative and nitrosative stresses to
kill C. albicans (Wilson et al., 2009; Cheng et al., 2012;
Mayer et al., 2013) (see Figure 1). The respiratory burst as
summarized by Faro-Trindade and Brown (2009) is mediated
via the phagocyte NADPH oxidase (Phox). This membrane-
associated protein complex generates superoxide through the
transfer of electrons from NADPH to O2. The generated
superoxide (O−2 ) has little, if any, toxicity but can be converted
to hydrogen peroxide (H2O2) and hydroxyl radicals (HO
−)
with candidacidal activity. Myeloperoxidase (MPO), an enzyme
located in granules of neutrophils and in lysosomes of monocytes
(and even macrophages when they scavenge it through their
mannose receptors), catalyzes the further conversion of hydrogen
peroxide to hypochlorous acid (HClO). The hypochlorous acid
in turn is an extremely toxic and effective candidacidal oxidant.
The production of nitric oxide (NO) is induced by the inducible
nitric oxide synthase (iNOS or NOS2) through the oxidative
deamination of L-arginine. The NO itself has poor candidacidal
activity but can further react with the superoxide (O−2 ), generated
by the respiratory burst (Vazquez-Torres et al., 1996; Faro-
Trindade and Brown, 2009). The so produced peroxynitrite
(ONOO−), an unstable structural isomer of nitrate (NO−3 ), is
very effective at killing C. albicans (Vazquez-Torres et al., 1996;
Faro-Trindade and Brown, 2009; Cheng et al., 2012). As the
production of ROS and nitrosative stress are major antifungal
mechanisms in phagocytes, C. albicans possesses several defense
strategies to counteract the oxidative and nitrosative stresses
(Cheng et al., 2012; Mayer et al., 2013).
The response of C. albicans to ROS is regulated by Cap1
(adenylate cyclase-associated protein 1) and the MAP (mitogen-
activated protein) kinase Hog1. Both proteins regulate the
catalase expression in C. albicans (Lopez, 2013). The fungus
can produce antioxidant enzymes like the catalase Cta1 and
intracellular as well as extracellular superoxide dismutases (Sods)
to counteract the respiratory burst (Faro-Trindade and Brown,
2009; Frohner et al., 2009; Cheng et al., 2012; Mayer et al.,
2013; Miramón et al., 2013). Of the intracellular Sods, Sod1
is required for interaction with macrophages and Sod2 is
necessary to resist neutrophil attack (Miramón et al., 2013).
Next to the catalase Cta1, the superoxide dismutases Sod5,
Sod4 (Frohner et al., 2009) and Sod6 detoxify extracellular ROS
produced by macrophages (Lopez, 2013). The expression of
Sods is depending on the fungal morphology. While Sod4 is
expressed by C. albicans yeast cells, the hyphal forms express
Sod5 (Miramón et al., 2013). Neutrophils also induce the
expression of Sod5 even though they inhibit the yeast-to-hyphal
formation in C. albicans (Frohner et al., 2009; Miramón et al.,
2013). Furthermore, in response to incubation with neutrophils
Sods, catalase, glutathione peroxidase, glutathione reductase,
glutathione S-transferase and thioredoxin are strongly induced
in C. albicans cells (Wilson et al., 2009). The superoxide
detoxification generates H2O2 which is still highly toxic but
subsequently eliminated by Cat1. The glutathione peroxidases
(Gpxs) also detoxify H2O2 via oxidation of the thiolgroups in
FIGURE 1 | Depiction of oxidative and nitrosative stress imposed
on phagocytosed C. albicans and its detoxification by the fungus.
The Curved lines indicate cell membranes of the phagocyte, the
phagolysosome and, most inside, the C. albicans cell. Abbreviations:
iNOS, inducible nitric oxide synthase; Cta1, catalase 1; Sod1-6,
superoxide dismutases 1–6; Gpxs, glutathione peroxidases; GRX2 and
GRL1 encode glutathione reductases; Yhb1, Yhb4, and Yhb5,
flavohemoglobin 1, 4, and 5; Hog1, mitogen-activated protein kinase;
Cap1, adenylate cyclase-associated protein; Cta4, transcription factor;
Cwt1, cell wall transcription factor.
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two glutathione molecules, which are subsequently reduced by
glutathione reductases (Grxs), encoded by GRX2 and GRL1
(Miramón et al., 2013). In addition C. albicans up-regulates DNA
damage repair systems and heat shock proteins to counteract
oxidative damage to nucleic acids and proteins (Faro-Trindade
and Brown, 2009). The exposure to moderate concentrations of
ROS induces the entire arginine biosynthetic pathway but no
other amino acid synthetic genes in phagocytosed C. albicans
cells (Lopez, 2013).
The nitrosative stress response of C. albicans is mediated by
the three intracellular flavohemoglobin enzymes Yhb1, Yhb4,
and Yhb5 (Lopez, 2013; Mayer et al., 2013) which convert
NO to less toxic NO−3 molecules (Luo et al., 2013). The
nitrosative stress response is regulated by the two transcription
factors Cta4 and Cwt1. While Cta4 positively regulates the
transcriptional nitrosative stress response, Cwt1 negatively
regulates it (Miramón et al., 2013).
2.2.6. Extracellular Traps
The production of extracellular traps (ETs) is a phagocytosis
independent antimicrobial mechanism observed inmany effector
cells including neutrophils and macrophages (Pruchniak et al.,
2012; Branzk and Papayannopoulos, 2013; Hahn et al., 2013; Liu
et al., 2014). These fiber-like extracellular structures are induced
by many different microbes including C. albicans (Faro-Trindade
and Brown, 2009), chemicals and cytokines (Liu et al., 2014).
As being significantly associated with the microbial surface ETs
are thought to act as a physical barrier that prevents invading
pathogens from further progressing. The formation of ETs was
therefore proposed as supplementary strategy by the host defense
when phagocytosis failed to eliminate the invading pathogen (Liu
et al., 2014).
Neutrophil extracellular traps (NETs) occur as specialized
form of neutrophils cell death and consist of DNA scaffolds
with antimicrobial proteins like histones and granule proteins
including myeloperoxidase, elastase, cathelicidins, cathepsin G,
calprotectins and gelatinase B (Faro-Trindade and Brown, 2009;
Urban et al., 2009; Moyes and Naglik, 2011; Liu et al., 2014).
Releasing these effector molecules into the extracellular space
allows neutrophils to efficiently trap and kill the yeast and hyphal
forms of C. albicans (Faro-Trindade and Brown, 2009; Liu et al.,
2014). While this is beneficial for the host defense, NETs also
participate in propagating some autoimmune diseases such as
systemic lupus erythematosus and small vessel vasculitis (Liu
et al., 2014).
C. albicans cells also induce the formation of METs like
structures (METs-LS). TheseMETs-LS can be released by dying as
well as viable macrophages and thus show more than one type of
composition. While some METs-LS consist of a DNA backbone
and microbicidal proteins including histone, myeloperoxidase
and lysozyme, other METs-LS did not contain histone. As
histones are associated with nuclear DNA it was proposed that
the DNA backbone in those METs-LS without histone originates
from mitochondrial DNA. In contrast to NETs, METs-LS are
not capable to efficiently kill C. albicans cells. Instead METs-LS
rather contain the invading pathogen at the infection site, thereby
preventing the systemic diffusion of C. albicans and providing
time to recruit other effector cells like neutrophils (Liu et al.,
2014).
While the formation of ETs usually depends on the generation
of ROS via the activation of the NADPH oxidase, C. albicans
induces NETs andMETs-LS in an ROS independent manner (Liu
et al., 2014).
3. Computational Systems Biology
Approaches
In many fields of biology, Computational Systems Biology
approaches have turned out to be very useful (Heinrich and
Schuster, 1996; Klipp et al., 2011). Various Systems Biology
methods for understanding and predicting fungal virulence have
been reviewed by Tierney et al. (2014). For other organisms, it
has been shown that network analyses are useful to describe and
understand the manifold interactions between a pathogen and its
host (Naseem et al., 2012).
The basis for many Systems Biology approaches is provided
by high throughput data. There are several studies regarding the
omics of Candida. For instance, eight Candida genomes were
compared by Butler et al. (2009). They found large families and
genome expansions regarding the cell wall, secreted proteins
and transporters, in particular in pathogenic species. These
adaptations seemed thus to be associated with virulence.
Comprehensive transcriptome data were collected by Bruno
et al. (2010). Measuring gene expression they identified 602
novel transcriptionally active regions. Conditions included
hyphae-induction, tissue culture, high and low oxidative stress,
nitrosative stress as well as cell wall damage-inducing conditions.
Regarding the omics of infection, there are in principle
also dual sequencing approaches feasible but this is not really
explored yet. Instead, Liu et al. (2015) investigated the host
response to C. albicans infection in various niches and derived
exciting results. Network analysis, siRNA knock down and
RNAseq data identified new host signaling pathways under
infection such as platelet-derived growth factor BB (PDGF
BB) and neural precursor-cell-expressed developmentally down-
regulated protein 9 (NEDD9). Both proteins regulate the uptake
of C. albicans by host cells.
Regarding metabolite data, there is a lipidomics study by
Singh et al. (2013) studying changes in C. albicans caused by
fluconazole, a drug against candidiasis. Under this treatment,
C. albicans shows an increased sterol content and depleted
sphingolipid levels in case of azole resistance.
As evidenced by omics data many mechanisms and
phenomena in biology (e.g., entangled positive and negative
feedback loops) are so complex that they cannot be understood
by intuition. This is one reason for the ever increasing
importance of computer simulations. A first and important step
is to explain known phenomena on theoretical grounds, thus
helping us to understand them. The usefulness of this aspect of
Computational Systems Biology should not be underestimated.
A famous early example is the Michaelis-Menten kinetics.
This formal approach helps us to understand the role of the
association and dissociation of the enzyme-substrate complex.
Frontiers in Microbiology | www.frontiersin.org 10 June 2015 | Volume 6 | Article 625
Dühring et al. Human defense and C. albicans evasion strategies
It has a predictive aspect because it allows one to calculate the
reaction velocity even for substrate concentrations for which no
measurement has been performed for a specific enzyme so far.
The most ambitious goal is to predict hitherto unknown
properties, interactions and behaviors. Several studies show that
Computational Systems Biology approaches can generate clear
testable predictions that could later be confirmed in experiments
(Schuster et al., 2006) or highlight new working hypotheses
for in vitro experiments (Siegismund et al., 2014a,b). The latter
study investigates the early colonization of bacteria on different
biomaterials typically used for implants. Automated images
analysis of CLSM images and point-pattern analysis were applied
to show material-induced switches from bacterial adhesion to
colony growth on biomaterials. By two- or three-dimensional
modeling, e.g., using cellular automata or agent-based models,
the adhesion of pathogens and/or epithelial cells of the host
on implant surfaces can be simulated. For the case of bacteria,
see Siegismund et al. (2014b). This helps us to understand the
onset of disease in the case where the pathogens win this “race
for the surface” (Subbiahdoss et al., 2009) and the avoidance
of disease in the case where the host cells win. This will also
help to devise novel therapeutic strategies, as an appropriate
surface structure of the implants can diminish adhesion by
pathogens. A model for the thermal adaptation of Candida based
on a differential equation system was proposed by Leach et al.
(2012). That model appropriately describes the defense-evasion
pair “fever—heat shock response.” Moreover, other modeling
techniques have been used to study Candida infections, such as
Bayesian modeling (Shankar et al., 2015) and dynamic interactive
infectious networks (Chen and Wu, 2014).
Several defense and evasion mechanism have been described
by mathematical modeling. For example, the action of
degradative enzymes can be simulated by kinetic models of
metabolic networks (Heinrich and Schuster, 1996). Kinetic
models of tryptophan metabolism (Stavrum et al., 2013) and of
multi-drug resistance pumps have been published (Westerhoff
et al., 2000). A large body of literature on the modeling of
biofilm formation is available (Audretsch et al., 2013), though
mostly on bacterial rather than fungal biofilms, for a review
see Horn and Lackner (2014). Moreover, a gene regulatory
network was inferred (Tierney et al., 2012). All of those modeling
techniques could in principle be applied to investigateC. albicans’
interactions with the host.
In the present chapter, we outline themodelingmethods based
on game theory and agent-based models in more detail.
3.1. Game theory
Metaphorically, the struggle between pathogens and the human
immune system can be considered as a game in which each player
attempts to win (Renaud and De Meeus, 1991; Hummert et al.,
2014). This metaphor is quite useful because it allows one to
understand that struggle as an extended optimization process.
The extension is that the two counterparts (players) cannot
always reach the optimal state because they may hinder each
other in reaching it. Thus, suboptimal states can result (Hofbauer
and Sigmund, 1998). A considerable number of game-theoretical
models of bacterial and viral infections have been proposed, for a
review see Hummert et al. (2014), while fungal infections are the
subject of such studies to a lesser extent so far. To our knowledge,
Hummert et al. (2010) were the first to present a game-theoretical
model of the interaction of C. albicans with the human immune
system, in particular, with human macrophages. The simplifying
assumption used was that C. albicans has two strategies when
engulfed bymacrophages: avoiding lysis transiently (silencing) or
undergoing a morphological switch to form hyphae and escaping
(piercing). The latter situation corresponds to the defense-
evasion pair “phagocytosis—pyroptosis.” In the approach by
Hummert and coworkers, different Candida cells are considered
as players while the macrophage was considered as a constant
environment. Thus, a symmetric game results and the fitness
matrix can be written as follows:
p s
p l− c l− c
s
(
1− e−λ
)
l 0
where s and p stand for the silencing and piercing strategies,
respectively, l stands for the benefit of surviving, c for having
payed the costs for piercing and λ denotes the average number of
engulfed cells. A Poisson distribution for the number of ingested
C. albicans yeast cells was assumed.
Every entry in the fitness matrix gives the payoff of an
individual playing a row strategy against a pure population
playing the column strategy. Under certain parameter conditions,
a pure piercing population can exist. For other parameter
values, a mixed evolutionary stable strategy (ESS) results, which
corresponds to coexistence of silencing and piercing cells. The
silencing cells then benefit from the efforts made by the piercing
cells. In game-theoretical terms, this is a hawk-dove game
(Hofbauer and Sigmund, 1998; Stark, 2010). Both of the above-
mentioned outcomes are in good agreement with experimental
observations, because two different karyotypes had been found
(Tavanti et al., 2006).
A related model was established to describe the switch from
yeast to hyphae upon invasion of human tissues (rather than
inside macrophages) (Tyc et al., 2014). These authors extended
the model by differential equations, allowing them to describe
the dynamic behavior. Two situations are compared: cooperation
between yeast and hyphae forms, meaning that the yeast form
will also benefit when some cells switch to become hyphae, and
competition, in which coexistence of yeast and hyphal cells pays
off only to the hyphae. The model predicts that cooperation
among fungal cells occurs in mild infections and an enhanced
tendency to invade the host is associated with the competitive
behavior (Tyc et al., 2014).
Recent progress investigated the iterative Prisoners’ Dilemma.
Interestingly, there is an incentive for cooperativity under
these circumstances. It is worthwhile to use these mathematical
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insights in the context of recurrent Candida infections (an often
happening medical condition). As known for different bacterial
strains such as Pseudomonas in Mucoviscidosis there should be
some signs for selection for mitigated strains in such repeated
Candida infections. Furthermore, dictator strategies force a
certain win or loss on the opponent, no matter which strategy
is chosen (Axelrod and Hamilton, 1981). Such a way of action
should be the typical strategy of the immune system in the healthy
person but has not yet been extensively investigated, in particular
as such healthy persons rarely undergo clinical investigation.
In contrast to the game between different Candida cells,
the “game” between the immune system and pathogens is
an asymmetric game. A pioneering paper on that type of
description was published by Renaud and De Meeus (1991) for
the general case of any pathogen. The two players can choose
between an aggressive strategy (called the “killer” strategy) that
seeks to eliminate the adversary and a less aggressive strategy
(“diplomat”).
Renaud and De Meeus (1991) wrote down a rather general
payoff matrix involving several parameters. To illustrate the idea,
we here give a more specific matrix. However, the concrete
numbers do not matter as long as they fulfill certain order
relations. The entries in the matrix can be explained as follows.
If both sides adopt the “killer” strategy, they win with a certain
probability and have to afford the costs for that aggressive
behavior. This is here quantified by 1 for either side. If both adopt
the “diplomat” strategy, they can coexist and need not afford the
costs for aggression. Thus, they can gain, say, 5 points each. If the
host and parasite play “killer” and “diplomat,” respectively, the
latter will be eliminated (payoff of 0). The host survives but has
to afford some costs, so that its payoff is between 1 and 5 (here
assumed to be 3). In the converse situation, the host will die (or
at least become very sick), here quantified by 0. The parasite has
a benefit b and some cost c.
Parasite: Killer Diplomat
Host:
Killer 1, 1 3, 0
Diplomat 0, b− c 5, 5
The type of game depends on the difference b − c. If it is less
than 5, there are two stable Nash equilibria on the main diagonal:
“killer, killer” and “diplomat, diplomat.” Loosely speaking, we
can denote them by “war” and “peace.” The game is then related
to the coordination game, in which the two players have to
coordinate with each other to select among two symmetric Nash
equilibria (Stark, 2010). Although the peaceful situation is better
for both of them, they can get stuck in the war because neither
side can leave it unilaterally without decreasing its payoff even
more. It is worth noting that the non-lytic expulsion of C.
albicans cells from macrophages mentioned in Section 2.2.4 can
be considered as a peaceful situation as well.
If b − c > 5 (that is, high benefit or low cost of “killer”
strategy for the parasite), peace is no longer stable because there
is an incentive for the parasite to switch to the “killer” strategy.
The state “diplomat, killer” is not, however, stable either because
the host will then switch to “killer” as well. Thus, only war is
stable. This change of Nash equilibria is a suitable model for the
change from immunocompetent to susceptible hosts (e.g., after
antibiotics treatment due to change in bacterial flora). The cost c
for the parasite to invade the host then decreases, so that b − c
can exceed the critical threshold.
The situation where only war is stable in the killer-diplomat
game is quite paradoxical because both sides would be better off
if they were in peace with each other. This is reminiscent of the
famous Prisoners’ Dilemma, which is a symmetric game (Stark,
2010). In fact, the cause for instability is similar in both games:
it is the temptation (incentive) to leave the mutually beneficial
state. The difference between the two games is that, in the
Prisoners’ Dilemma, both players are tempted in this way while
in the killer-diplomat game, there is a temptation for the parasite
only.
3.2. Agent-based modeling
Agent-based models (ABMs) have become a powerful tool for
tackling complex systems, where the individuality, temporal state
and spatial distribution of its players may be of importance.
They are typically characterized by numerous interacting entities,
often called agents or individuals (depending on the discipline
so that the term individual-based model (IBM) is used as well).
They pursue certain objectives (e.g., increasing fitness, yield,
status) by following, more or less, simple structured rules. These
agents can be mobile or stationary units within a continuous
or discrete environment defined by three, two, one or even no
spatial dimension. In silico environments without any dimension
simply imply that the modeled system behavior is presumably
independent of any spatial scale. Including more dimensions
assumes that this may be of importance for the behavior of
the system: A model investigating the hunting strategies of
a terrestrial predator may be sufficiently described by a two-
dimensional environment. Whereas a third dimension has to be
considered simulating the movement of immune-cells through
different tissues or in the blood.
The philosophy of ABMs is to slice problems on the macro-
level down to simple interaction- and reaction-rules of players on
a micro-level. For example, patterns occurring on the population
level are transferred to properties and the behavior of single
individuals. Diseases of an individual can be explained by the
malfunction or disorder of organs and tissues. Often the macro-
level behavior of a system cannot be foreseen by only summing up
the rules of players. Instead, patterns may arise from the complex
interdigitation of state-dependent behavior of its entities, an
effect called emergence.
Resolving a macro-level pattern (emergence of a certain
behavior) to a lower complexity level comes at the price of a
detailed knowledge of the individuals properties and behavioral
strategies, which have to be precisely formulated. Especially
models representing a biological system frequently deal with
several involved types of agents (e.g., food-webs, stability of
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ecosystems) and numerous interactions often require a bottom-
up modeling approach with a deep knowledge of individual
properties. Thus, ABMs are typically hungry for data (e.g.,
thresholds for reaction to signals, kinetic parameters) and
computationally expensive due to, e.g., a frequent use of random
number generators to induce local and individual stochasticity.
Beside classical experimental approaches (e.g., for determining
growth-rates), image- and video-derived data offer a valuable
complementary solution to fill this gap of knowledge (Mech et al.,
2011, 2014).
Deviating from an equation-based modeling approach typical
ABMs show a considerable set of non-redundant rules. This often
poses difficulties to communicate ABMs. Grimm and colleagues
addressed this obstructive problem by proposing a standardized-
and later updated protocol to formalize the descriptions of ABMs
(Grimm et al., 2006, 2010).
Tokarski et al. (2012) investigated several hunting strategies of
alveolar macrophages for fungal spores of Aspergillus fumigatus.
The clearing efficiency of the immune system represented
the emergent property of this system. Different scenarios of
interactions between both players were tested, e.g., random walk
of macrophages; detection and guidance of macrophages along
local gradients of degradation products, indicating sporulation
of spores and positive feedback activation of macrophages which
already detected fungal spores. This approach exemplarily shows
that biological systems above a certain degree of complexity,
would be hard, if not impossible, to handle with an equation-
based model. System properties may only arise at such a high
complexity, e.g., by the local, state-dependent interactions of
several agents (see Figure 2).
Due to its strengths in representing complex systems, ABMs
show a broad field of scientific applications incorporating
ecological (DeAngelis andGrimm, 2014) andmicrobial questions
(Kreft et al., 2013).
ABM approaches helped to understand the epidemic spread
of diseases, e.g., influenza (Milne et al., 2008; Laskowski et al.,
2011) and Ebola (Merler et al., 2015) or, the microbial resistance
to antibiotics in Staphylococcus aureus (Macal et al., 2014). But
were also utilized to test the efficiency of counter-strategies for
disease control (Borkowski et al., 2009; Tian et al., 2013; Havas
et al., 2014).
Ideally ABMs can predict biological mechanisms or strategies
which were unknown from wet-lab experiments, showing
that both approaches are not competitive but complementary.
Pollmächer and Figge (2014) investigated migration modes
of macrophages and predicted that their efficiency of finding
conidia could only be explained by the release of chemotactic
signals from epithelial cells associated with Aspergillus fumigatus.
The human immune defense system consists of a dense
mesh of state-dependent interactions between numerous types of
players (e.g., pathogens, neutrophils or dendritic cells). Cascades
of signal molecules are steering the induction and inhibition of
cell responses and locally trigger the mobilization of different
defense levels (e.g., passive, innate and acquired).
Folcik et al. (2007) examined the complex interplay between
the innate and adaptive parts of the immune system. The focus
was on the qualitative response to a viral infection. That work
FIGURE 2 | Screenshot of a typical ABM simulation (taken from
Tokarski et al., 2012), displaying the hunt of free-moving neutrophil
agents (black circles) for immobile spore agents of Aspergillus
fumigatus in human lung tissue. Spores can be free (orange), temporarily
dragged (yellow) or caught (red) by a neutrophil agent. Dragged spores may be
released with a certain probability or caught and phagocytosed (gray).
Neutrophil agents are able to detect chemokines (blue), released by spores
during sporulation, and may adjust their movement accordingly.
showed that all parts of the immune system are non-redundant
and deficiency in any components increased the probability of
failure to clear the simulated viral infection.
Baldazzi et al. (2006) investigated anti-HIV therapy with a
immune-system model of multiple immune-cell types. ABMs
typically show a high degree of specificity, thus representing one
specific issue of a complex system in detail. Thus, ABMs are often
less general and hard to transfer to similar questions. Examples
addressing specific pathogens are: Clostridium (Peer and An,
2014), Pseudomonas aeruginosa (Seal et al., 2011), Leishmania
(Dancik et al., 2010), Helicobacter pylori (Carbo et al., 2013),
and Aspergillus fumigatus (Tokarski et al., 2012; Pollmächer and
Figge, 2014). Tyc and Klipp (2011) suggested how to combine the
complex behaviors of both, the host and the pathogen. Extensive
reviews regarding ABMs of the immune system can be found in
Chavali et al. (2008); Bauer et al. (2009); Li et al. (2008); Forrest
and Beauchemin (2007).
4. Discussion
In this review, we have given an overview of the immune
defense mechanisms of the human host against C. albicans and
the evasion mechanisms of the fungus to escape, circumvent
or counteract the immune response. Both the terms defense
and evasion are here used in a wide sense and may include
attack mechanisms. While earlier reviews have given an overview
of experimental observations on C. albicans defense and
evasion strategies, we present here an integrative synthesis of
experimental observation and theoretical modeling of infection
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strategies of C. albicans. Our review extends previous efforts on
this topic (Zipfel et al., 2013).
On the basis of the list of mechanisms and strategies,
given in Tables 1, 2, it is of interest to search for even
higher levels of interaction, that is, whether there are cascades
including counter-counter defenses. For example Streptomyces
clavuligerus produces both penicillin and clavulanic acid, a β-
lactamases inhibitor (Reading and Cole, 1977; Knowles, 1985).
Clavulanic acid and other β-lactamase inhibitors like sulbactam
and tazobactam, limit the destructive action of β-lactamases
from bacteria against β-lactam compounds such as penicillins
and cephalosporins (Williams, 1997). Thus, there are three
levels in the case of Streptomyces clavuligerus: penicillin as a
defense chemical, β-lactamases as an evasion (counter-defense)
mechanism by bacteria and clavulanic acid as a counter-counter
defense. To our knowledge, no counter-counter defense is known
in the case of C. albicans so far. However, Qiao et al. (2013)
showed that other eukaryotic pathogens, i.e., oomycetes, are able
to suppress RNA silencing, for a review see Pumplin and Voinnet
(2013). Examples for counter-counter defense strategies are
also known from plant-virus interactions, i.e., by antagonizing
the virus-induced downregulation of RNA silencing by the
plant (Sansregret et al., 2013). An intriguing question in the
microbiology of pathogens is: How deep such an arms race of a
host-pathogen interaction may evolve? Or, in other words: Are
organisms rather selected for a counter-counter defense or an
evolutionary novel mechanism of direct defense. The efficiency
of multiple and complex layers of defense and counter-defense
can be described mathematically by methods from Operations
Research (Abt, 1987).
As the examples given above like macrophage phagocytosis
and pyroptosis show, it can be hard to predict the outcome
of the struggle between the human immune system and
C. albicans. A special focus of our review therefore lies
on the discussion of various Systems Biology approaches.
Those are undoubtedly a promising tool to represent complex
host-pathogen interactions and allow for the emergence of
observed in vivo outcomes and for extensive testing scenarios
(e.g., medication, drug testing, cross-effects). For example the
acquisition of human complement regulators to the cell surface
can be considered as a molecular mimicry. Mathematical models
of mimicry in higher organisms can be adapted to describe
this phenomenon. Systems Biology approaches are instrumental
for questions which are hard to conduct solely in laboratory
experiments. Nevertheless, theoretical approaches have to be
substantially supported and completed by in vivo and in vitro
approaches.
In Tables 1, 2, both specialist and generalist effector
mechanisms can be seen. One example for a generalist effector
is the C. albicans protein Pra1 as it exerts several effects. In the
terminology of networks analysis, Pra1 is a hub. Accordingly,
it is of interest in future studies to analyze how complex and
entangled the network of interactions is, whether it is scale-
free or has small-world properties etc. (Yook et al., 2004). These
properties are relevant in view of robustness against errors and
mutations (Albert et al., 2000).
Another interesting question is how the host protects itself
from its own “attack” mechanisms such as oxidative and
nitrosative stress. Obviously, the levels of these substances should
not exceed upper limits. This, in turn, might give a chance for
C. albicans in its evasion strategies. Moreover, an optimal trade-
off between immunity and autoimmunity as in the case of NETs
must be found which also implies upper limits on the degree
of defense. In this context, the camouflage by C. albicans using
factor H is worth mentioning.
On or within the human host C. albicans not only interacts
with the host but also with all the probiotic microorganisms
of the host’s microflora. It is therefore worthwhile to further
look into these interactions, e.g., C. albicans’ theft of iron from
siderophores produced by other microorganisms via its own
siderophore uptake system. Kleptoparasitism can be investigated
using game theoretic models, considering individuals as well as
groups (Broom and Rychtárˇ, 2011). To our knowledge this has
not been done for C. albicans so far.
All these topics are prone to be analyzed by mathematical
modeling and computer simulations. Some of the computational
methods such as agent-based models allow one to describe both
temporal and spatial aspects. Ideally, in-silico modeling makes it
possible to reduce the number of experiments with animals and
ethically questionable or prohibited experiments with humans.
This helps to gain further insight and make medically important
predictions, for instance regarding onset of fungal sepsis
and novel intervention strategies in the immunocompromised
patient.
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